2017 Q4 Form 10-K Financial Statement

#000156459018004269 Filed on March 02, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2017
Revenue $1.961M $2.287M $1.650B
YoY Change 60.34% 78.12% 32900.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $8.500M $2.100M $14.00M
YoY Change 286.36% 50.0% 100.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $59.00M
YoY Change
% of Gross Profit
Operating Expenses $8.000M $2.200M $1.475B
YoY Change 788.89% 37.5% 24483.33%
Operating Profit -$2.483M
YoY Change -3283.33%
Interest Expense -$3.000M $38.20M $731.0M
YoY Change -102.14% -334.36% 27843.43%
% of Operating Profit
Other Income/Expense, Net $0.00 $100.0K -$131.0M
YoY Change -100.0% -164.97%
Pretax Income -$9.000M $38.40M $44.00M
YoY Change -106.41% -331.33% -78.19%
Income Tax $0.00 $0.00 $13.00M
% Of Pretax Income 0.0% 29.55%
Net Earnings -$9.000M $38.40M $30.00M
YoY Change -106.41% -331.33% -85.13%
Net Earnings / Revenue -458.95% 1679.06% 1.82%
Basic Earnings Per Share -$0.07 $0.06 $0.31
Diluted Earnings Per Share -$0.07 $0.06 $0.30
COMMON SHARES
Basic Shares Outstanding 97.70M shares
Diluted Shares Outstanding 98.80M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2017
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.00M $26.00M $27.00M
YoY Change 1250.0% 766.67% 1250.0%
Cash & Equivalents $215.0M $26.00M $27.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $27.00M $26.00M $27.00M
YoY Change 1250.0% 766.67% 1250.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $8.000M $17.00M $8.000M
YoY Change -89.87% -80.0% -89.87%
Other Assets $579.0M $577.0M $579.0M
YoY Change 1.05% 0.7% 1.05%
Total Long-Term Assets $18.01B $707.0M $587.0M
YoY Change 2353.54% 7.28% -20.03%
TOTAL ASSETS
Total Short-Term Assets $27.00M $26.00M $27.00M
Total Long-Term Assets $18.01B $707.0M $587.0M
Total Assets $18.04B $733.0M $614.0M
YoY Change 2350.54% 10.73% -16.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $0.00 $0.00 $0.00
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Long-Term Liabilities $17.00M $15.00M $17.00M
YoY Change -19.05% -81.71% -19.05%
Total Long-Term Liabilities $17.00M $15.00M $17.00M
YoY Change -57.5% -85.29% -57.5%
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities $17.00M $15.00M $17.00M
Total Liabilities $16.82M $14.60M $17.00M
YoY Change -57.96% -85.69% -57.5%
SHAREHOLDERS EQUITY
Retained Earnings $93.55M $107.1M
YoY Change 9.14%
Common Stock $2.000K $2.000K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $93.59M $215.9M $597.0M
YoY Change
Total Liabilities & Shareholders Equity $614.1M $732.7M $614.0M
YoY Change -16.58% 10.69% -16.58%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2017
OPERATING ACTIVITIES
Net Income -$9.000M $38.40M $30.00M
YoY Change -106.41% -331.33% -85.13%
Depreciation, Depletion And Amortization $59.00M
YoY Change
Cash From Operating Activities $5.000M -$4.000M $1.359B
YoY Change 400.0% 300.0% -19514.29%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions $0.00
YoY Change
Other Investing Activities $7.000M $13.00M $73.00M
YoY Change 16.67% 160.0% 231.82%
Cash From Investing Activities $7.000M $13.00M -$6.000M
YoY Change 16.67% 160.0% -127.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $4.000M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.000M -22.00M -$1.655B
YoY Change 0.0% 266.67% 7780.95%
NET CHANGE
Cash From Operating Activities 5.000M -4.000M $1.359B
Cash From Investing Activities 7.000M 13.00M -$6.000M
Cash From Financing Activities -5.000M -22.00M -$1.655B
Net Change In Cash 7.000M -13.00M -$302.0M
YoY Change 250.0% 550.0% 4933.33%
FREE CASH FLOW
Cash From Operating Activities $5.000M -$4.000M $1.359B
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 us-gaap Other Liabilities
OtherLiabilities
16303000
CY2017Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
503713000
CY2017Q4 us-gaap Liabilities
Liabilities
16816000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017 us-gaap Gain Loss On Investments
GainLossOnInvestments
6670000
CY2015 us-gaap Revenues
Revenues
6000000
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
206714132
CY2015 wmih Gain Loss On Contract Fair Market Value Reserve
GainLossOnContractFairMarketValueReserve
2926000
CY2017 us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
383000
CY2015 wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
-1115000
CY2017 us-gaap Insurance Commissions
InsuranceCommissions
137000
CY2016 us-gaap Insurance Commissions
InsuranceCommissions
306000
CY2015 us-gaap Insurance Commissions
InsuranceCommissions
456000
CY2016Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Asset
EmbeddedDerivativeFairValueOfEmbeddedDerivativeAsset
80651000
CY2016Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
203000
CY2016Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
811000
CY2016Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
53000
CY2017 wmih Operating Expenses Benefits
OperatingExpensesBenefits
10373000
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
206714132
CY2017 us-gaap Premiums Earned Net
PremiumsEarnedNet
1220000
CY2017 wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
19000
CY2016 wmih Policyholder Losses And Loss Adjustment Expense Benefit
PolicyholderLossesAndLossAdjustmentExpenseBenefit
-669000
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7043000
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20940000
CY2017 wmih Gain Loss On Contract Fair Market Value Reserve
GainLossOnContractFairMarketValueReserve
5645000
CY2016 wmih Gain Loss On Contract Fair Market Value Reserve
GainLossOnContractFairMarketValueReserve
3978000
CY2016 us-gaap Interest Expense
InterestExpense
2616000
CY2015 us-gaap Interest Expense
InterestExpense
3702000
CY2016 wmih Operating Expenses Benefits
OperatingExpensesBenefits
5318000
CY2015 wmih Operating Expenses Benefits
OperatingExpensesBenefits
21057000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-2483000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
78000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-15057000
CY2017 wmih Other Income Expense
OtherIncomeExpense
123000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
9778000
CY2015 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
324000
CY2016 us-gaap Trading Securities Unrealized Holding Gain Loss
TradingSecuritiesUnrealizedHoldingGainLoss
-41000
CY2015 us-gaap Increase Decrease In Accrued Investment Income Receivable
IncreaseDecreaseInAccruedInvestmentIncomeReceivable
-241000
CY2016 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-212000
CY2015 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-157000
CY2016 wmih Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
-1511000
CY2015 wmih Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
-7435000
CY2016 wmih Other Income Expense
OtherIncomeExpense
123000
CY2015 wmih Other Income Expense
OtherIncomeExpense
7845000
CY2017 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
28242000
CY2016 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
201499000
CY2015 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-54621000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
28365000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-46776000
CY2016 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-208237000
CY2015 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
47653000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6537000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14180000
CY2016 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
180439000
CY2015 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
269694000
CY2016 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
202419000
CY2015 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
230567000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
21980000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39127000
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-61833000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-61833000
CY2017 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
18050000
CY2016 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
18000000
CY2015 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
17748000
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
183700000
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79581000
CY2017 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.33
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202595288
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
202270887
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
201746613
CY2017 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2016 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
CY2015 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
212660917
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
235406360
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
201746613
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
88230000
CY2015 us-gaap Dividends Preferred Stock
DividendsPreferredStock
17748000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1129000
CY2017 us-gaap Dividends Preferred Stock
DividendsPreferredStock
18050000
CY2017 wmih Adjustments To Additional Paid In Capital Reclassification Of Derivative Asset
AdjustmentsToAdditionalPaidInCapitalReclassificationOfDerivativeAsset
108893000
CY2017 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
116000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
517000
CY2017 wmih Increase Decrease In Cash Held In Trust
IncreaseDecreaseInCashHeldInTrust
2023000
CY2016 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-4252000
CY2015 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
-13884000
CY2017 wmih Increase Decrease In Losses Payable
IncreaseDecreaseInLossesPayable
-53000
CY2016 wmih Increase Decrease In Losses Payable
IncreaseDecreaseInLossesPayable
-352000
CY2015 wmih Increase Decrease In Losses Payable
IncreaseDecreaseInLossesPayable
-291000
CY2017 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-231000
CY2016 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-491000
CY2015 us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
-333000
CY2017 wmih Increase Decrease In Accrued Ceding Commission Expense
IncreaseDecreaseInAccruedCedingCommissionExpense
-22000
CY2016 wmih Increase Decrease In Accrued Ceding Commission Expense
IncreaseDecreaseInAccruedCedingCommissionExpense
-11000
CY2015 wmih Increase Decrease In Accrued Ceding Commission Expense
IncreaseDecreaseInAccruedCedingCommissionExpense
-11000
CY2017 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-203000
CY2016 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-33000
CY2017 us-gaap Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense
ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense
<div> <p style="margin-bottom:6pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The components of the liability for losses and loss adjustment reserves are as follows as of December&#160;31, 2017 and 2016, respectively: </p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:80.74%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:20.04%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2017</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.38%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2016</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Case-basis reserves</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.04%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">151</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.38%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">553</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:56.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IBNR reserves</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.04%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.38%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8212;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Premium deficiency reserves</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.04%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">322</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">258</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:56.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total losses and loss adjustment reserves</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.04%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">474</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">811</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div>
CY2014Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
80456000
CY2015 wmih Accrued Fees Relating To Stock Issuance
AccruedFeesRelatingToStockIssuance
12250000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
605645000
CY2017 us-gaap Interest Paid
InterestPaid
1991000
CY2015 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-102000
CY2017 wmih Increase Decrease In Loss Contract Fair Market Value Reserve
IncreaseDecreaseInLossContractFairMarketValueReserve
5645000
CY2016 us-gaap Interest Paid
InterestPaid
2647000
CY2016 wmih Increase Decrease In Loss Contract Fair Market Value Reserve
IncreaseDecreaseInLossContractFairMarketValueReserve
3978000
CY2015 wmih Increase Decrease In Loss Contract Fair Market Value Reserve
IncreaseDecreaseInLossContractFairMarketValueReserve
2926000
CY2017 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3740000
CY2016 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-294000
CY2015 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
904000
CY2017 us-gaap Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities
AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities
-32299000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-6417000
CY2017 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
19974000
CY2017 us-gaap Proceeds From Sale And Maturity Of Trading Securities Heldforinvestment
ProceedsFromSaleAndMaturityOfTradingSecuritiesHeldforinvestment
93022000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
73048000
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
600000000
CY2015 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
19310000
CY2017 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
18050000
CY2016 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
18000000
CY2015 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
16998000
CY2017 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
18774000
CY2016 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2969000
CY2015 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
10395000
CY2015 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
918000
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-36824000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-20969000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
554215000
CY2017 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
29807000
CY2016 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5526000
CY2015 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
500908000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
575838000
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
581364000
CY2015 us-gaap Interest Paid
InterestPaid
2887000
CY2017 wmih Noncash Reclassification Of Derivative Asset
NoncashReclassificationOfDerivativeAsset
108893000
CY2015 wmih Noncash Reclassification Of Derivative Asset
NoncashReclassificationOfDerivativeAsset
66227000
CY2015 us-gaap Notes Issued1
NotesIssued1
918000
CY2015 wmih Non Cash Redeemable Convertible Series B Preferred Stock Dividends Accrued
NonCashRedeemableConvertibleSeriesBPreferredStockDividendsAccrued
750000
CY2017 wmih Accrued Fees Relating To Stock Issuance
AccruedFeesRelatingToStockIssuance
-1500000
CY2015Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2177746000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with Generally Accepted Accounting Principles in the United States (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. Management has made significant estimates in certain areas, including valuing certain financial instruments, other assets and liabilities, the determination of the contingent risk liabilities, and in determining appropriate insurance reserves. Actual results could differ substantially from those estimates. </p></div>
CY2017 us-gaap Plan Of Reorganization Dates Plan Is Effective
PlanOfReorganizationDatesPlanIsEffective
2012-03-19
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2017Q4 wmih Premium Deficiency Reserves
PremiumDeficiencyReserves
300000
CY2016Q4 wmih Premium Deficiency Reserves
PremiumDeficiencyReserves
300000
CY2017Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
4700000
CY2016Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
1100000
CY2017 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0
CY2017 wmih Amount Of Dividends Paid On Or After Effective Date
AmountOfDividendsPaidOnOrAfterEffectiveDate
0
CY2009Q3 wmih Quoted Percentage To Share Base
QuotedPercentageToShareBase
0.50
CY2017 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
989000
CY2016 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
2656000
CY2015 us-gaap Assumed Premiums Earned
AssumedPremiumsEarned
4788000
CY2015Q4 us-gaap Liability For Claims And Claims Adjustment Expense
LiabilityForClaimsAndClaimsAdjustmentExpense
5063000
CY2017 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
19000
CY2016 us-gaap Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense
SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense
-669000
CY2017 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
356000
CY2016 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
3583000
CY2017Q4 wmih Loss Contract Value Reserve Balance
LossContractValueReserveBalance
0
CY2016Q4 wmih Loss Contract Value Reserve Balance
LossContractValueReserveBalance
5600000
CY2017 wmih Loss Contract Value Reserve Decrease
LossContractValueReserveDecrease
5600000
CY2016 wmih Loss Contract Value Reserve Decrease
LossContractValueReserveDecrease
4000000
CY2015 wmih Loss Contract Value Reserve Decrease
LossContractValueReserveDecrease
2900000
CY2012Q1 wmih Loss Contract Value Reserve Balance
LossContractValueReserveBalance
63100000
CY2017Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
3674000
CY2017 us-gaap Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
14000
CY2017Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
3660000
CY2016Q4 us-gaap Trading Securities Debt Amortized Cost
TradingSecuritiesDebtAmortizedCost
76912000
CY2016 us-gaap Trading Securities Unrealized Holding Gain
TradingSecuritiesUnrealizedHoldingGain
15000
CY2016 us-gaap Trading Securities Unrealized Holding Loss
TradingSecuritiesUnrealizedHoldingLoss
96000
CY2016Q4 us-gaap Trading Securities Debt
TradingSecuritiesDebt
76831000
CY2016Q4 wmih Valuation Allowance Equal To Net Deferred Federal Income Tax Asset
ValuationAllowanceEqualToNetDeferredFederalIncomeTaxAsset
1.00
CY2015Q4 wmih Valuation Allowance Equal To Net Deferred Federal Income Tax Asset
ValuationAllowanceEqualToNetDeferredFederalIncomeTaxAsset
1.00
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2107353000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.379
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.270
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.00
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2017 wmih Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Assets Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxAssetsProvisionalIncomeTaxBenefit
842900000
CY2017Q4 wmih Valuation Allowance Equal To Net Deferred Federal Income Tax Asset
ValuationAllowanceEqualToNetDeferredFederalIncomeTaxAsset
1.00
CY2017Q4 wmih Fixed Maturity Securities Debt Maturities Within One Year Amortized Cost
FixedMaturitySecuritiesDebtMaturitiesWithinOneYearAmortizedCost
3674000
CY2017Q4 wmih Fixed Maturity Securities Debt Maturities Within One Year Fair Value
FixedMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
3660000
CY2016Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
81379000
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
0.807
CY2016 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
0.034
CY2015 us-gaap Effective Income Tax Rate Reconciliation Deductions Dividends
EffectiveIncomeTaxRateReconciliationDeductionsDividends
-0.080
CY2017 wmih Effective Income Tax True Up Of Deferred Assets
EffectiveIncomeTaxTrueUpOfDeferredAssets
0.137
CY2016 wmih Effective Income Tax True Up Of Deferred Assets
EffectiveIncomeTaxTrueUpOfDeferredAssets
-0.005
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
107.666
CY2017 wmih Effective Income Tax Rate Reconciliation Expiration Of Capital Loss Carryforward
EffectiveIncomeTaxRateReconciliationExpirationOfCapitalLossCarryforward
6.629
CY2017 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.137
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
115.452
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2104944000
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2102482000
CY2017Q4 wmih Deferred Tax Assets Change In Net Operating Loss Due To Change In Tax Rates
DeferredTaxAssetsChangeInNetOperatingLossDueToChangeInTaxRates
-842941000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
309000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
2177000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves
3481000
CY2015Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
19117000
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
138000
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
157000
CY2015Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
160000
CY2017Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
4000
CY2016Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
23000
CY2015Q4 us-gaap Deferred Tax Assets Unrealized Losses On Trading Securities
DeferredTaxAssetsUnrealizedLossesOnTradingSecurities
16000
CY2017Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
344000
CY2016Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
52475000
CY2015Q4 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
52490000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
1265207000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2159776000
CY2017Q4 wmih Deferred Tax Liabilities Tax Deferred Expense Losses And Loss Adjustments Expense
DeferredTaxLiabilitiesTaxDeferredExpenseLossesAndLossAdjustmentsExpense
304000
CY2015Q4 wmih Deferred Tax Liabilities Tax Deferred Expense Losses And Loss Adjustments Expense
DeferredTaxLiabilitiesTaxDeferredExpenseLossesAndLossAdjustmentsExpense
411000
CY2016Q4 wmih Deferred Tax Liabilities Tax Deferred Expense Losses And Loss Adjustments Expense
DeferredTaxLiabilitiesTaxDeferredExpenseLossesAndLossAdjustmentsExpense
500000
CY2016Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
51407000
CY2017Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
304000
CY2016Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
51907000
CY2015Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
411000
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1264903000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2107869000
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2177335000
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2012Q1 wmih Non Operating Loss Due To Abandonment Of Stock
NonOperatingLossDueToAbandonmentOfStock
8400000000
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6021010000
CY2017 wmih Net Operating Loss Expiration Date
NetOperatingLossExpirationDate
2031
CY2016 wmih Capital Loss Carryforward Expiration Year
CapitalLossCarryforwardExpirationYear
2017
CY2017 wmih Capital Loss Carryforward Subject To Expiration Year
CapitalLossCarryforwardSubjectToExpirationYear
2018
CY2017Q4 wmih Operating Loss Carryforwards Taxable
OperatingLossCarryforwardsTaxable
7610808000
CY2017Q4 wmih Operating Loss Carryforwards Limitations
OperatingLossCarryforwardsLimitations
1589798000
CY2017Q4 wmih Reserve For Uncertain Federal Income Tax Position
ReserveForUncertainFederalIncomeTaxPosition
0
CY2017 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2016 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2015 us-gaap Income Tax Examination Penalties And Interest Expense
IncomeTaxExaminationPenaltiesAndInterestExpense
0
CY2017 us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2011
CY2016Q4 us-gaap Cash Collateral For Borrowed Securities
CashCollateralForBorrowedSecurities
400000
CY2017Q4 wmih Number Of Debt Financing Arrangements
NumberOfDebtFinancingArrangements
0
CY2016Q4 wmih Number Of Debt Financing Arrangements Other Than Second Lien Notes
NumberOfDebtFinancingArrangementsOtherThanSecondLienNotes
0
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2015Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3500000000
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2014Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
61400000
CY2017 wmih Class Of Warrant Or Right Warrants Expiration Period
ClassOfWarrantOrRightWarrantsExpirationPeriod
P5Y
CY2017 wmih Registration Rights Agreement Blackout And Lockups Period
RegistrationRightsAgreementBlackoutAndLockupsPeriod
P180D
CY2015Q1 us-gaap Escrow Deposit
EscrowDeposit
598500000
CY2017Q4 us-gaap Escrow Deposit
EscrowDeposit
578900000
CY2016Q4 us-gaap Escrow Deposit
EscrowDeposit
572900000
CY2017 us-gaap Business Acquisition Description Of Acquired Entity
BusinessAcquisitionDescriptionOfAcquiredEntity
. “Acquisition” means any acquisition by the Company (or any of its direct or indirect wholly-owned subsidiaries), in a single transaction or a series of transactions, whether by purchase, merger or otherwise, of all or substantially all of the assets of, or of 80% or more of the equity interests in, or a business line, unit or division of, any person.
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2017 wmih Additional Share Based Compensation Restricted Stock Awards Outstanding Restricted Stock Awards Granted
AdditionalShareBasedCompensationRestrictedStockAwardsOutstandingRestrictedStockAwardsGranted
1015872
CY2017Q4 wmih Share Based Compensation Unvested Restricted Awards Outstanding Unamortized
ShareBasedCompensationUnvestedRestrictedAwardsOutstandingUnamortized
3538000
CY2016Q4 wmih Share Based Compensation Unvested Restricted Awards Outstanding Unamortized
ShareBasedCompensationUnvestedRestrictedAwardsOutstandingUnamortized
7700000
CY2015Q4 wmih Share Based Compensation Unvested Restricted Awards Outstanding Unamortized
ShareBasedCompensationUnvestedRestrictedAwardsOutstandingUnamortized
10000000
CY2017Q4 wmih Share Based Compensation Unamortized Restricted Fair Value Awards Subject To Vesting Schedule
ShareBasedCompensationUnamortizedRestrictedFairValueAwardsSubjectToVestingSchedule
516000
CY2017Q4 wmih Share Based Compensation Unamortized Restricted Fair Value Dependent Awards Outstanding
ShareBasedCompensationUnamortizedRestrictedFairValueDependentAwardsOutstanding
3022000
CY2017 wmih Repurchase Price Unvested Common Stock
RepurchasePriceUnvestedCommonStock
0.0001
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
206168035
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
206168035
CY2017Q4 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
CY2016Q4 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
CY2015Q4 wmih Warrants Issued To Purchase Of Common Stock
WarrantsIssuedToPurchaseOfCommonStock
61400000
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-54621000
CY2017Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
13289000
CY2017Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61400000
CY2016Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61400000
CY2015Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
61400000
CY2017Q4 us-gaap Loss Contingency Pending Claims Number
LossContingencyPendingClaimsNumber
0
CY2017 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
0
CY2017 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
18050000
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
18000000
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
17748000
CY2017 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
5417000
CY2016 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
116774000
CY2017 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
2415000
CY2016 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
66926000
CY2015 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Basic
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersBasic
-79581000
CY2017 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
206576233
CY2016 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
206291857
CY2015 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
204776405
CY2017 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3980945
CY2016 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4020970
CY2015 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3029792
CY2017 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
5417000
CY2016 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
112115000
CY2017 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
2415000
CY2016 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
71585000
CY2015 wmih Net Income Loss After Adjustment Of Preferred Stock Dividends And Undistributed Earnings Of Participating Securities To Common Stockholders Diluted
NetIncomeLossAfterAdjustmentOfPreferredStockDividendsAndUndistributedEarningsOfParticipatingSecuritiesToCommonStockholdersDiluted
-79581000
CY2017 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
10065629
CY2016 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
33135473
CY2015 us-gaap Incremental Common Shares Attributable To Equity Forward Agreements
IncrementalCommonSharesAttributableToEquityForwardAgreements
0
CY2017 us-gaap Payments For Repurchase Of Warrants
PaymentsForRepurchaseOfWarrants
84400000
CY2015 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
-66227000
CY2015Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
-120848000
CY2016 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
201499000
CY2016Q4 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis With Unobservable Inputs
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
80651000
CY2017 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
28242000
CY2017 wmih Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Reclassification Of Derivative Asset
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationReclassificationOfDerivativeAsset
-108893000
CY2017 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.60
CY2016 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.40
CY2017 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.016
CY2016 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.006
CY2017 wmih Fair Value Inputs Expected Probability Of Qualified Acquisition
FairValueInputsExpectedProbabilityOfQualifiedAcquisition
0.95
CY2016 wmih Fair Value Inputs Expected Probability Of Qualified Acquisition
FairValueInputsExpectedProbabilityOfQualifiedAcquisition
0.90
CY2017 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P9M
CY2016 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P6M
CY2017 wmih Change In Fair Value Of Derivative Assets Recognized In Earnings
ChangeInFairValueOfDerivativeAssetsRecognizedInEarnings
28200000
CY2017 wmih Fair Market Value Of Derivative Liability Transferred To Equity
FairMarketValueOfDerivativeLiabilityTransferredToEquity
108900000
CY2017Q1 us-gaap Revenues
Revenues
1610000
CY2017Q2 us-gaap Revenues
Revenues
2032000
CY2017Q3 us-gaap Revenues
Revenues
2287000
CY2017Q4 us-gaap Revenues
Revenues
1961000
CY2016Q1 us-gaap Revenues
Revenues
1500000
CY2016Q2 us-gaap Revenues
Revenues
1389000
CY2016Q3 us-gaap Revenues
Revenues
1284000
CY2016Q4 us-gaap Revenues
Revenues
1223000
CY2015Q1 us-gaap Revenues
Revenues
1750000
CY2015Q2 us-gaap Revenues
Revenues
1470000
CY2015Q3 us-gaap Revenues
Revenues
1488000
CY2015Q4 us-gaap Revenues
Revenues
1292000
CY2017Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-25824000
CY2017Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
33911000
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-13544000
CY2016Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
51050000
CY2016Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17909000
CY2016Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-21145000
CY2016Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
135886000
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1253000
CY2015Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-77983000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8419000
CY2015Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
5568000
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.06
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.24
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.39
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2015Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.06
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.23
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.39
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2015Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01

Files In Submission

Name View Source Status
0001564590-18-004269-index-headers.html Edgar Link pending
0001564590-18-004269-index.html Edgar Link pending
0001564590-18-004269.txt Edgar Link pending
0001564590-18-004269-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018030205350102131617.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wmih-10k_20171231.htm Edgar Link pending
wmih-20171231.xml Edgar Link completed
wmih-20171231.xsd Edgar Link pending
wmih-20171231_cal.xml Edgar Link unprocessable
wmih-20171231_def.xml Edgar Link unprocessable
wmih-20171231_lab.xml Edgar Link unprocessable
wmih-20171231_pre.xml Edgar Link unprocessable
wmih-ex1023_232.htm Edgar Link pending
wmih-ex1025_684.htm Edgar Link pending
wmih-ex1027_683.htm Edgar Link pending
wmih-ex1033_1077.htm Edgar Link pending
wmih-ex121_505.htm Edgar Link pending
wmih-ex14_12.htm Edgar Link pending
wmih-ex21_681.htm Edgar Link pending
wmih-ex231_504.htm Edgar Link pending
wmih-ex311_7.htm Edgar Link pending
wmih-ex312_11.htm Edgar Link pending
wmih-ex321_6.htm Edgar Link pending
wmih-ex322_8.htm Edgar Link pending